Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yolanda Johnson"'
Autor:
Aimee K. Hildenbrand, Allison A. King, Constance A Mara, Yolanda Johnson, Lisa M Shook, Catharine Whitacre, Maria T Britto, Charles T. Quinn, William Brinkman, Rogelle Hackworth, Jean L. Raphael, Venee N. Tubman, Alexis A. Thompson, Kim Smith-Whitley, Sherif M. Badawy, Susan E. Creary, Neha Bhasin, Marsha Treadwell, Steven K Reader, Angeli Rampersad, Amy Sobota, Lori E. Crosby
Publikováno v:
Blood. 140:10857-10859
Autor:
David Davis, Kenyon Hackworth, Francis J. Real, William B. Brinkman, Lori E. Crosby, Anna M Hood, Rogelle Hackworth, Melissa Klein, Bradley Cruse, Charles T. Quinn, Emily McTate, Yolanda Johnson
Publikováno v:
Hood, A 2021, ' An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia ', Journal of pediatric hematology/oncology . https://doi.org/10.1097/mph.0000000000002289
J Pediatr Hematol Oncol
J Pediatr Hematol Oncol
Although hydroxyurea (HU) is an effective treatment for sickle cell anemia, uptake remains low. Shared decision making (SDM) is a recommended strategy for HU initiation to elicit family preferences; however, clinicians lack SDM training. We implement
Autor:
Heather Strong, Anna M Hood, Yolanda Johnson, Rogelle Hackworth, Marque Reed-Shackelford, Rohit Ramaswamy, Taniya Varughese, Charles T Quinn, Lori E Crosby
Publikováno v:
Clinical Trials. :174077452311541
Background/Aims: Recruitment is often a barrier in clinical trials that include minoritized populations, such as individuals with sickle cell disease. In the United States, the majority of people with sickle cell disease identify as Black or African
Autor:
Nixon, Vivian, Clough, Patricia Ticento, Staples, David, Peterkin, Yolanda Johnson, Zimmerman, Patricia, Voight, Christina, Clear, Sean Pica
Publikováno v:
Race/Ethnicity: Multidisciplinary Global Contexts, 2008 Oct 01. 2(1), 21-43.
Externí odkaz:
https://www.jstor.org/stable/25594997
Autor:
Allison A. King, Anna M Hood, Kim Smith-Whitley, Steven K Reader, Aimee K. Hildenbrand, Connie M. Piccone, Marsha Treadwell, Francis J. Real, Charles T. Quinn, Lisa M Shook, Jean L. Raphael, Cara Nwankwo, Amy Sobota, Yolanda Johnson, Amber M Yates, Maria T. Britto, Rogelle Hackworth, Susan E Creary, William B. Brinkman, Kay L. Saving, James Peugh, Lori E. Crosby, Heather Strong, Sohail Rana, Alexis A. Thompson, Lynne Neumayr, Melissa Klein, Sherif M. Badawy, Cecelia Calhoun, Constance A. Mara, Emily Riehm Meier, Russell E. Ware
Publikováno v:
JMIR Research Protocols, Vol 10, Iss 5, p e27650 (2021)
JMIR Research Protocols
Hood, A M, Strong, H, Nwankwo, C, Johnson, Y, Peugh, J, Mara, C A, Shook, L M, Brinkman, W B, Real, F J, Klein, M D, Hackworth, R, Badawy, S M, Thompson, A A, Raphael, J L, Yates, A M, Smith-Whitley, K, King, A A, Calhoun, C, Creary, S E, Piccone, C M, Hildenbrand, A K, Reader, S K, Neumayr, L, Meier, E R, Sobota, A E, Rana, S, Britto, M, Saving, K L, Treadwell, M, Quinn, C T, Ware, R E & Crosby, L E 2021, ' Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea : Protocol for a Multicenter Randomized Controlled Trial ', JMIR research protocols, vol. 10, no. 5, e27650 . https://doi.org/10.2196/27650
JMIR Research Protocols
Hood, A M, Strong, H, Nwankwo, C, Johnson, Y, Peugh, J, Mara, C A, Shook, L M, Brinkman, W B, Real, F J, Klein, M D, Hackworth, R, Badawy, S M, Thompson, A A, Raphael, J L, Yates, A M, Smith-Whitley, K, King, A A, Calhoun, C, Creary, S E, Piccone, C M, Hildenbrand, A K, Reader, S K, Neumayr, L, Meier, E R, Sobota, A E, Rana, S, Britto, M, Saving, K L, Treadwell, M, Quinn, C T, Ware, R E & Crosby, L E 2021, ' Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea : Protocol for a Multicenter Randomized Controlled Trial ', JMIR research protocols, vol. 10, no. 5, e27650 . https://doi.org/10.2196/27650
Background Sickle cell anemia (SCA) is a genetic blood disorder that puts children at a risk of serious medical complications, early morbidity and mortality, and high health care utilization. Until recently, hydroxyurea was the only disease-modifying
Autor:
Anna M Hood, Heather Strong, Cara Nwankwo, Yolanda Johnson, James Peugh, Constance A Mara, Lisa M Shook, William B Brinkman, Francis J Real, Melissa D Klein, Rogelle Hackworth, Sherif M Badawy, Alexis A Thompson, Jean L Raphael, Amber M Yates, Kim Smith-Whitley, Allison A King, Cecelia Calhoun, Susan E Creary, Connie M Piccone, Aimee K Hildenbrand, Steven K Reader, Lynne Neumayr, Emily R Meier, Amy E Sobota, Sohail Rana, Maria Britto, Kay L Saving, Marsha Treadwell, Charles T Quinn, Russell E Ware, Lori E Crosby
BACKGROUND Sickle cell anemia (SCA) is a genetic blood disorder that puts children at a risk of serious medical complications, early morbidity and mortality, and high health care utilization. Until recently, hydroxyurea was the only disease-modifying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a584f8f48b0e173db2375c45e3d8948b
https://doi.org/10.2196/preprints.27650
https://doi.org/10.2196/preprints.27650
Autor:
Ronda, Wright, Kristina, Roberson, Elijah O, Onsomu, Yolanda, Johnson, Cathy, Dearman, Loneke T Blackman, Carr, Amanda Alise, Price, Vanessa, Duren-Winfield
Publikováno v:
Journal of best practices in health professions diversity : research, education and policy. 11(1)
College students are prone to stress, making them vulnerable to cardiovascular disease (CVD). Harmful health behaviors, such as tobacco or alcohol use, further predispose students to hypertension (HTN). African-Americans (AA) experience increased blo
Autor:
Yolanda Johnson-Moton, Elizabeth K. McClain, Rebecca J. Bartlett Ellis, Bryan Larsen, Eric C. Niederhoffer
Publikováno v:
Industry and Higher Education. 32:302-311
The approach to building innovative partnerships between academia and the pharmaceutical industry has expanded to investigate collaborations that offer meaningful outcomes beyond discovery and increased productivity. This case study uses a systems th
Autor:
Charles T. Quinn, Alexis A. Thompson, Anna M Hood, Jasmine Stallworth, Constance A. Mara, Yolanda Johnson, Emily Riehm Meier, Helge Hartung, Lisa M Shook, Lori E. Crosby, Kim Smith-Whitley, Allison A. King, Venee N. Tubman, Stacey M. Gomes, Amber M Yates, Aimee K. Hildenbrand, Jean L. Raphael, Joanna Rebitski, Catharine Whitacre, Sherif M. Badawy, Neha Bhasin, Steven K Reader, Susan E Creary
Publikováno v:
Blood
Background: Hydroxyurea (HU) is the primary medication used to prevent the significant medical and neurologic morbidities of pediatric sickle cell disease (SCD; HbSS or HbSB0 thalassemia). Despite the benefits of HU, it remains under-utilized likely
Autor:
Cara Nwankwo, Amy Sobota, Lynne Neumayr, Constance A. Mara, Lori E. Crosby, Kay L. Saving, Anna M Hood, Sohail Rana, Yolanda Johnson, Cecelia Calhoun, Francis J. Real, Allison A. King, Maria T. Britto, Susan E Creary, Steven K Reader, Aimee K. Hildenbrand, Lisa M Shook, Emmanuel J. Volanakis, Alexis A. Thompson, William B. Brinkman, Charles T. Quinn, Jean L. Raphael, Sherif M. Badawy, Emily Riehm Meier, Amber M Yates, Melissa Klein, Connie M. Piccone, Heather Strong, Kim Smith-Whitley
Publikováno v:
Blood. 136:26-27
Background: Sickle cell disease (SCD) is a genetic disorder that causes significant medical and neurologic morbidity in children. Hydroxyurea (HU) is the primary medication used to prevent these complications. National Heart, Lung, and Blood Institut